Ysios Capital

Ysios Capital accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $1.5B. The median disclosed raise is $83M, and the largest is AM Pharma at $176M, ahead of Splice Bio ($170M) and SparingVision ($147M).

The names that recur most often on these co-invested cap tables are Ysios Capital (15 companies), Gilde Healthcare (6 companies), Kurma Partners (4 companies), Novartis Venture Fund (4 companies), LSP (3 companies), Sanofi Ventures (3 companies). By latest disclosed round, the market skews Series A (7), Series C (4), Series B (3), Growth (1).

• Companies tracked: 15
• Disclosed funding total: $1.5B across 15 companies
• Median disclosed raise: $83M
• Largest raise: AM Pharma — $176M
• Stage mix: Series A 7 · Series C 4 · Series B 3 · Growth 1
• Most recent dated round: 2025-06-01

Best funded Ysios Capital companies

1. AM Pharma — $176M (latest: Series C)
2. Splice Bio — $170M (latest: Series B)
3. SparingVision — $147M (latest: Series B)
4. Minoryx Therapeutics — $138M (latest: Series C)
5. Neurona Therapeutics — $126M (latest: Series B)
6. Xeltis — $119M (latest: Series C)
7. VarmX — $103M (latest: Growth)
8. Lava Therapeutics — $83M (latest: Series C)
9. ADC Therapeutics — $65M (latest: Series A)
10. ReproNovo — $65M (latest: Series A)
11. Tagworks Pharmaceuticals — $65M (latest: Series A)
12. ADCendo — $62M (latest: Series A)
13. Kynexis — $61M (latest: Series A)
14. Cytoki Pharma — $45M (latest: Series A)
15. Vivet Therapeutics — $41M (latest: Series A)

Ysios Capital — related firms and companies (56)

• AM Pharma
• Splice Bio
• SparingVision
• Minoryx Therapeutics
• Neurona Therapeutics
• Xeltis
• VarmX
• Lava Therapeutics
• Ysios Capital portfolio companies 2026
• Investors like Bling Capital
• ADCendo
• Investors like Irving Investors
• Investors like Acre Venture Partners
• Investors like SoftBank Vision Fund
• Investors like CAVU Consumer Partners
• Investors like Forerunner
• Investors like Maven Ventures
• Investors like Bienville Capital
• Investors like Ventioneers
• Investors like Bessemer Venture Partners
• Investors like Oak HC/FT
• Vivet Therapeutics
• Investors like Casdin Capital
• Tagworks Pharmaceuticals
• Investors like BoxGroup
• Investors like Thirdbase Capital
• Investors like Canaan Partners
• Investors like Accel
• Investors like Menlo Ventures
• Investors like SV Angel
• Investors like Foundation Capital
• Investors like Battery Ventures
• Companies backed by Ysios Capital
• Investors like Bain Capital Ventures
• Cytoki Pharma
• Investors like Matrix
• ReproNovo
• Investors like Goldman Sachs
• Investors like 500 Global
• Investors like IVP
• Investors like Bain Capital
• Investors like Betaworks
• Investors like Uncork Capital
• Investors like Franklin Templeton
• Investors like Venrock
• Investors like Ysios Capital
• Investors like Lux Capital
• Kynexis
• Investors like Accomplice
• ADC Therapeutics
• Investors like Great Oaks Venture Capital
• Investors like Notable Capital
• Investors like F-Prime
• Investors like Torch Capital
• Investors like Alexandria Venture Investments
• Investors like Thrive Capital

Ysios Capital profile · All research reports